EPO and anemia: While traditional paradigms have centered on erythropoietin deficiency and iron dysregulation, it is now evident that accelerated erythrocyte death—driven by uremic toxins, oxidative stress, chronic inflammation, and iron imbalance—plays a critical role in reducing red blood cell lifespan and exacerbating anemia.